Pituitary-adrenocortical response to acute and chronic administration of U-50 488H in the rat

Howlett, 1986, Endogenous opioid peptides and hypothalamo-pituitary function, Ann. Rev. Physiol., 48, 527, 10.1146/annurev.ph.48.030186.002523 Lightman, 1988, Corticotropin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat, J. Physiol., 403, 511, 10.1113/jphysiol.1988.sp017261 Zis, 1984, Morphine inhibits cortisol and stimulates prolactin secretion in man, Psychoneuroendocrinology, 9, 423, 10.1016/0306-4530(84)90050-7 Buckingham, 1982, Secretion of corticotropin and its hypothalamic releasing factor in response to morphine and opioid peptides, Neuroendocrinology, 35, 111, 10.1159/000123364 Jezova, 1982, ACTH and corticosterone response to naloxone and morphine in normal, hypophysectomised and dexamethasone treated rats, Life Sci., 31, 307, 10.1016/0024-3205(82)90407-6 Iyengar, 1986, Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat, J. Pharmacol. Exp. Ther., 238, 429 Buckingham, 1984, Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine, Neurendocrinology, 38, 411, 10.1159/000123927 Martínez, 1990, Plasma B-endorphin and cortisol levels in morphine-tolerant rats and in naloxone-induced withdrawal, Eur. J. Pharmacol., 182, 117, 10.1016/0014-2999(90)90499-V Pechnick, 1985, Identification of multiple opioid receptors through neuroendocrine response. I. Effects of agonists, J. Pharmacol. Exp. Ther., 232, 163 Yajima, 1986, Effects of opioid peptides on immunoreactive corticotropin releasing factor release from the rat hypothalamus in vitro, Life Sci., 39, 181, 10.1016/0024-3205(86)90453-4 Buckingham, 1987, Modulation of the secretion of corticotropin releasing factor (CRF) by opioid substances, Br. J. Pharmacol., 90, 167 Bhargava, 1989, Effects of morphine in rats treated chronically with U-50488H, a k-opioid receptor agonist, Eur. J. Pharmacol., 162, 257, 10.1016/0014-2999(89)90288-4 Gulati, 1989, Effect of repeated administration of U-50488H, a kappa opioid receptor agonist, on control 5-HT1, and 5-HT2 receptors in the rat, Pharmacology, 29, 145, 10.1159/000138591 Ho, 1989, Serotonergic involvement in the antinociceptive action of and the development of tolerance of the kappa-opioid receptor agonist, U-50488H, J. Pharmacol. Exp. Ther., 250, 508 Eidemberg, 1985, Plasma corticosterone changes in response to control or peripheral administration of kappa and sigma opiate agonist, J. Pharmacol. Exp. Ther., 233, 863 Cowan, 1988, Direct dependence studies in rats with agents selective for different types of opioid receptors, J. Pharmacol. Exp. Ther., 246, 950 Von Voigtlander, 1983, U-50488H: A selective and structurally novel non-mu (kappa) opioid agonist, J Pharmacol. Exp. Ther., 224, 7 Katovich, 1986, Effects of opioid antagonists and their quaternary analogs on temperature changes in morphine-dependent rats, Life Sci., 39, 1845, 10.1016/0024-3205(86)90294-8 Nikolarakis, 1987, The role of CRF in the relase of ACTH by opiate agonists and antagonists in rats, Brain Res., 421, 373, 10.1016/0006-8993(87)91311-4 Pfeiffer, 1985, Central k- and μ-opiate receptors mediate ACTH release in rats, Endocrinology, 116, 2688, 10.1210/endo-116-6-2688 Suemaru, 1985, Effects of morphine on hypothalamic corticotropin-releasing factor (CRF), norepinephrine and dopamine in non-stressed and stressed rats, Acta Med. Okayama, 39, 463 Cover, 1989, Effects of selective opioid-receptor blockade on the hypothalamo-pituitary-adrenocortical responses to surgical trauma in the rat, J. Endocrinol., 211, 213, 10.1677/joe.0.1210213 Magnan, 1982, The binding spectrum of narcótic analgesic drugs with different agonist and antagonist properties, Atch Pharmacol., 319, 197, 10.1007/BF00495865 Facchinetti, 1984, Impaired circadian rhythmicity of B-lipotropin, B-endorphin and ACTH in heroin addicts, Acta Endocrinologica, 105, 149, 10.1530/acta.0.1050149 O'Brien, 1988, Endogenous opioids in cerebrospinal fluid of opioids-dependent humans, Biol. Psychiat, 24, 649, 10.1016/0006-3223(88)90139-4 von Voigtlander, 1981, U-50488H (trans-3,4-dichloro-N-methyl-N-(2-1-pyrronolidinyl)-benzeneace tamide)-Prototype for a new class of opioid, Pharmacologist, 23, 134 Ramao, 1988, Effect of U-50488H, a kappa opioid receptor agonist on tolerance to its pharmacological effects and brain and espinal cord kappa opioid receptors, Am. Soc. Pharmacol. Exp. Ther., 30, A126 Gmerek, 1986, Kappa receptor mediated opioid dependence in rhesus monkeys, Life Sci., 39, 987, 10.1016/0024-3205(86)90287-0 McFadzean, 1988, The ionic mechanisms underlying opioid actions, Neuropeptides, 11, 173, 10.1016/0143-4179(88)90072-8 North, 1986, Opioid receptors types and membrane ion channels, Trends Neurosci., 9, 114, 10.1016/0166-2236(86)90038-X Chniweiss, 1988, Mu and delta opiates receptors coupled negatively to adenylate cyclase on embryonic neurons from the mouse striatum in primare cultures, J. Neurosci., 8, 3376, 10.1523/JNEUROSCI.08-09-03376.1988 Duman, 1988, Acute and chronic opiate-regulation of adenylate cyclase in brain: Specific effects in locus coeruleus, J. Pharmacol. Exp. Ther., 246, 1033 Sharma, 1975, Morphine receptors as regulators of adenylate cyclase activity, 72, 590 Collier, 1980, Cellular site of opiate dependence, Nature, 283, 625, 10.1038/283625a0